A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daewoong Pharmaceutical Co. LTD.
The study design is a randomized, double-blind, multicenter clinical trial. The patients were randomly assigned to each group. Primary endpoint was the change of MSSBP based on baseline between Treatment arm and control 1 arm and the change of LDL-C based on baseline between arm and control 2 arm.
Age
19–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 19 to 80 years
Patients with hypertension and hyperlipidemias
You may not be if
Orthostatic hypotension
History of ventricular tachycardia, atrial fibrillation
Uncontrolled diabetes mellitus
Clareo Health | A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
